{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:22:03Z","timestamp":1792794123707,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"24","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100011102","name":"European Union, 7th Framework Programme","doi-asserted-by":"crossref","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011102","name":"European Union, 7th Framework Programme","doi-asserted-by":"crossref","award":["n\u00b0602202"],"award-info":[{"award-number":["n\u00b0602202"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"name":"German Heart Research Foundation, German Cardiac Society","id":[{"id":"https:\/\/ror.org\/02yjb3a91","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\u2003<\/jats:title>\n                    <jats:p>Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) still reaches excessively high mortality rates. This analysis is aimed to develop a new easily applicable biomarker-based risk score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results\u2003<\/jats:title>\n                    <jats:p>A biomarker-based risk score for 30-day mortality was developed from 458 patients with CS complicating AMI included in the randomized CULPRIT-SHOCK trial. The selection of relevant predictors and the coefficient estimation for the prognostic model were performed by a penalized multivariate logistic regression analysis. Validation was performed internally, internally externally as well as externally in 163 patients with CS included in the randomized IABP-SHOCK II trial. Blood samples were obtained at randomization. The two trials are registered with ClinicalTrials.gov (NCT01927549 and NCT00491036), are closed to new participants, and follow-up is completed. Out of 58 candidate variables, the four strongest predictors for 30-day mortality were included in the CLIP score (cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide). The score was well calibrated and yielded high c-statistics of 0.82 [95% confidence interval (CI) 0.78\u20130.86] in internal validation, 0.82 (95% CI 0.75\u20130.89) in internal-external (temporal) validation, and 0.73 (95% CI 0.65\u20130.81) in external validation. Notably, it outperformed the Simplified Acute Physiology Score II and IABP-SHOCK II risk score in prognostication (0.83 vs 0.62; P\u2009&amp;lt;\u20090.001 and 0.83 vs. 0.76; P\u2009=\u20090.03, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\u2003<\/jats:title>\n                    <jats:p>A biomarker-only score for 30-day mortality risk stratification in infarct-related CS was developed, extensively validated and calibrated in a prospective cohort of contemporary patients with CS after AMI. The CLIP score outperformed other clinical scores and may be useful as an early decision tool in CS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab110","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T15:41:16Z","timestamp":1612971676000},"page":"2344-2352","source":"Crossref","is-referenced-by-count":133,"title":["The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction"],"prefix":"10.1093","volume":"42","author":[{"given":"Uta","family":"Ceglarek","sequence":"first","affiliation":[{"name":"Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital , P.-List-Str. 13, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5382-0083","authenticated-orcid":false,"given":"Paul","family":"Schellong","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital , P.-List-Str. 13, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3204-748X","authenticated-orcid":false,"given":"Maciej","family":"Rosolowski","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital , P.-List-Str. 13, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4059-1779","authenticated-orcid":false,"given":"Markus","family":"Scholz","sequence":"additional","affiliation":[{"name":"Institute of Medical Informatics, Statistics and Epidemiology, University Leipzig , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Willenberg","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital , P.-List-Str. 13, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Kratzsch","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital , P.-List-Str. 13, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Zeymer","sequence":"additional","affiliation":[{"name":"Klinikum Ludwigshafen und Institut f\u00fcr Herzinfarktforschung , Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3813-8772","authenticated-orcid":false,"given":"Georg","family":"Fuernau","sequence":"additional","affiliation":[{"name":"University Heart Center L\u00fcbeck , L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"de Waha-Thiele","sequence":"additional","affiliation":[{"name":"University Heart Center L\u00fcbeck , L\u00fcbeck, Germany"},{"name":"German Center for Cardiovascular Research (DZHK) , L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"B\u00fcttner","sequence":"additional","affiliation":[{"name":"Heart Center Leipzig at University of Leipzig, Department of Internal Medicine\/Cardiology, Str\u00fcmpellstr.. 39, 04289 Leipzig, and Leipzig Heart Institute, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Jobs","sequence":"additional","affiliation":[{"name":"German Center for Cardiovascular Research (DZHK) , L\u00fcbeck, Germany"},{"name":"Heart Center Leipzig at University of Leipzig, Department of Internal Medicine\/Cardiology, Str\u00fcmpellstr.. 39, 04289 Leipzig, and Leipzig Heart Institute, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Freund","sequence":"additional","affiliation":[{"name":"Heart Center Leipzig at University of Leipzig, Department of Internal Medicine\/Cardiology, Str\u00fcmpellstr.. 39, 04289 Leipzig, and Leipzig Heart Institute, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Desch","sequence":"additional","affiliation":[{"name":"German Center for Cardiovascular Research (DZHK) , L\u00fcbeck, Germany"},{"name":"Heart Center Leipzig at University of Leipzig, Department of Internal Medicine\/Cardiology, Str\u00fcmpellstr.. 39, 04289 Leipzig, and Leipzig Heart Institute, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Josef","family":"Feistritzer","sequence":"additional","affiliation":[{"name":"Heart Center Leipzig at University of Leipzig, Department of Internal Medicine\/Cardiology, Str\u00fcmpellstr.. 39, 04289 Leipzig, and Leipzig Heart Institute, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0714-6160","authenticated-orcid":false,"given":"Berend","family":"Isermann","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital , P.-List-Str. 13, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7606-1852","authenticated-orcid":false,"given":"Joachim","family":"Thiery","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital , P.-List-Str. 13, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"P\u00f6ss","sequence":"additional","affiliation":[{"name":"Heart Center Leipzig at University of Leipzig, Department of Internal Medicine\/Cardiology, Str\u00fcmpellstr.. 39, 04289 Leipzig, and Leipzig Heart Institute, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-998X","authenticated-orcid":false,"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[{"name":"Heart Center Leipzig at University of Leipzig, Department of Internal Medicine\/Cardiology, Str\u00fcmpellstr.. 39, 04289 Leipzig, and Leipzig Heart Institute, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"2022102603001498500_ehab110-B1","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102603001498500_ehab110-B2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jacc.2018.12.084","article-title":"Standardized team-based care for cardiogenic shock","volume":"73","author":"Tehrani","year":"2019","journal-title":"J Am Coll Card"},{"key":"2022102603001498500_ehab110-B3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2022102603001498500_ehab110-B4","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2017.02.027","article-title":"Risk stratification for patients in cardiogenic shock after acute myocardial infarction","volume":"69","author":"P\u00f6ss","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102603001498500_ehab110-B5","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2019.07.077","article-title":"Cardiogenic shock classification to predict mortality in the cardiac intensive care unit","volume":"74","author":"Jentzer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102603001498500_ehab110-B6","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"2022102603001498500_ehab110-B7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12-month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"2022102603001498500_ehab110-B8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"2022102603001498500_ehab110-B9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2015.04.242","article-title":"Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial","volume":"191","author":"Fuernau","year":"2015","journal-title":"Int J Cardiol"},{"key":"2022102603001498500_ehab110-B10","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/ejhf.342","article-title":"Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock\u2014a biomarker substudy of the IABP-SHOCK II-Trial","volume":"17","author":"Poss","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2022102603001498500_ehab110-B11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","article-title":"Towards better clinical prediction models: seven steps for development and an ABCD for validation","volume":"35","author":"Steyerberg","year":"2014","journal-title":"Eur Heart J"},{"key":"2022102603001498500_ehab110-B12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"2022102603001498500_ehab110-B13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jclinepi.2007.04.018","article-title":"Updating methods improved the performance of a clinical prediction model in new patients","volume":"61","author":"Janssen","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2022102603001498500_ehab110-B14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ahj.2010.06.024","article-title":"A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry","volume":"160","author":"Sleeper","year":"2010","journal-title":"Am Heart J"},{"key":"2022102603001498500_ehab110-B15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","article-title":"Prediction models need appropriate internal, internal-external, and external validation","volume":"69","author":"Steyerberg","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2022102603001498500_ehab110-B16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.amjcard.2008.12.033","article-title":"Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention","volume":"103","author":"Garcia-Alvarez","year":"2009","journal-title":"Am J Cardiol"},{"key":"2022102603001498500_ehab110-B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjcard.2005.02.040","article-title":"Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model","volume":"96","author":"Klein","year":"2005","journal-title":"Am J Cardiol"},{"key":"2022102603001498500_ehab110-B18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-8703(99)70241-3","article-title":"Cardiogenic shock complicating acute myocardial infarction: predictors of death","volume":"138","author":"Hasdai","year":"1999","journal-title":"Am Heart J"},{"key":"2022102603001498500_ehab110-B19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock","volume":"94","author":"Baran","year":"2019","journal-title":"Cathet Cardiovasc Interv"},{"key":"2022102603001498500_ehab110-B20","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1002\/ccd.28707","article-title":"Application of the SCAI classification in a cohort of patients with cardiogenic shock","volume":"96","author":"Schrage","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"2022102603001498500_ehab110-B21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ejhf.117","article-title":"Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial","volume":"16","author":"Fuernau","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2022102603001498500_ehab110-B22","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1097\/CCM.0000000000002336","article-title":"Combined measurement of soluble ST2 and amino-terminal pro-B-type natriuretic peptide provides early assessment of severity in cardiogenic shock complicating acute coronary syndrome","volume":"45","author":"Tolppanen","year":"2017","journal-title":"Crit Care Med"},{"key":"2022102603001498500_ehab110-B23","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1093\/eurheartj\/ehz294","article-title":"Protein-based cardiogenic shock patient classifier","volume":"40","author":"Rueda","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102603001498500_ehab110-B24","first-page":"1644","article-title":"Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36","volume":"63","author":"O'Malley","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022102603001498500_ehab110-B25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-8703(98)70041-9","article-title":"Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction","volume":"135","author":"Maeda","year":"1998","journal-title":"Am Heart J"},{"key":"2022102603001498500_ehab110-B26","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1161\/01.CIR.0000075927.67673.F2","article-title":"Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm","volume":"107","author":"Hochman","year":"2003","journal-title":"Circulation"},{"key":"2022102603001498500_ehab110-B27","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine for kidney function-based risk","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"2022102603001498500_ehab110-B28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009077","article-title":"Cystatin C for risk stratification in patients after an acute coronary syndrome","volume":"7","author":"Correa","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2022102603001498500_ehab110-B29","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.biocel.2009.05.005","article-title":"Macrophage responses to interferon-gamma are dependent on cystatin C levels","volume":"41","author":"Frendeus","year":"2009","journal-title":"Int J Biochem Cell Biol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/24\/2344\/46624591\/ehab110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/24\/2344\/46624591\/ehab110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T19:46:52Z","timestamp":1697831212000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/24\/2344\/6153946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":29,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,2,27]]},"published-print":{"date-parts":[[2021,6,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab110","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,21]]},"published":{"date-parts":[[2021,2,27]]}}}